Found 8 matching trials
NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer. PHASE1 The purpose of this study is to evaluate the change in the expression of tr...
Show More Status
Active Not Recruiting
Location
Nebraska Cancer Specialists
Learn More & Join Trial
68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer PHASE2 Prostate cancer (PC) remains the most-common non-cutaneous cancer diagnosed...
Show More Location
Stanford University, School of Medicine
Learn More & Join Trial
68-Ga PSMA 11 PET/MRI and 68-Ga RM2 PET/MRI for Evaluation of Prostate Cancer Response to HIFU Therapy PHASE1 This study is being conducted to determine whether the combination of imagi...
Show More Location
Stanford University
Learn More & Join Trial
68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer PHASE2 The objective of the study is to evaluate 68Ga PSMA 11 PET/MRI and 68Ga RM2...
Show More Location
Stanford University
Learn More & Join Trial
HDR Brachytherapy 68-Ga-RM2 PET, 68-Ga-PSMA-11 PET &Multi Parametric MRI in Prostate Cancer PHASE2 This study is being conducted to determine whether the combination of imagi...
Show More Location
Stanford Cancer Center
Learn More & Join Trial
68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate Cancer PHASE2 This clinical trial studies the use of gallium-68 (68Ga)-DOTA-Bombesin as t...
Show More Location
Stanford University Hospitals and Clinics
Learn More & Join Trial
PET/MR for Prostate Cancer Restaging: a Phase II Prospective Monocentric Study PHASE2 The overall goal is to provide an innovative approach to restage patients w...
Show More Location
IRCCS Ospedale San Raffaele
Learn More & Join Trial
68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer PHASE2 This phase II trial studies how well gallium Ga 68-labeled gastrin-releasin...
Show More Location
Stanford University, School of Medicine
Learn More & Join Trial